Printer Friendly

D-lactate: a novel contributor to metabolic acidosis and high anion gap in diabetic ketoacidosis.

To the Editor:

Diabetic ketoacidosis (DKA), the most common and serious acute complication of diabetes, is characterized by hyperglycemia and severe high-anion-gap metabolic acidosis with ketonemia (1). In DKA, the high anion gap is attributed largely to excessive production of blood ketone bodies, and serum [beta]-hydroxybutyrate quantification is recommended for the diagnosis and monitoring of DKA (2). However, even counting of all the ketone bodies, including [beta]-hydroxybutyrate, does not account for the entire anion gap, suggesting that there are additional sources of anion production in DKA.

We recently demonstrated that plasma D-lactate concentrations were greatly increased in DKA compared with the concentrations in diabetic patients or a healthy control group (3). Nevertheless, the clinical value of D-lactate measurement in metabolic acidosis, especially the contribution of D-lactate to the metabolic acidosis and high anion gap in DKA, is not well appreciated. We report here that decreasing D-lactate concentrations are associated with improved clinical situations, whereas increased lactate concentrations are associated with the severity of metabolic acidosis and high anion gap in patients with DKA.

[FIGURE 1 OMITTED]

The study included 38 diabetic patients with DKA, 42 diabetic patients without DKA, and 40 healthy controls. The institutional ethics review board of the First Affiliated Hospital of Wenzhou Medical College approved the study, and written informed consent was obtained from all study participants. For patients with DKA, blood samples were collected at the time of admission to the emergency room and following medical treatment after admission, when the patient's condition became stabilized. Plasma methylglyoxal was assayed by LC-MS (3). Plasma D-lactate concentration was determined by an enzymatic assay kit (BioVision Corporation). Other biochemical analyses were performed on automated chemistry analyzers.

Concentrations of plasma glucose [mean (SD) 450.45 (201.80) mg/dL], [beta]-hydroxybutyrate [58.41 (37.38) mg/dL], andmethylglyoxal [75.72 (46.25) ng/mL] were greatly increased compared with the concentrations in diabetic patients without DKA and healthy controls (all P < 0.001). Interestingly, plasma D-lactate concentrations were markedly increased in diabetic patients with DKA [3.44 (1.99) mmol/L] compared to diabetic patients without DKA [0.48 (0.56) mmol/L] and healthy controls [0.32 (0.30) mmol/L] (P < 0.001). Increased D-lactate concentrations were greatly reduced following treatment [3.44 (1.99) vs 0.53 (0.35) mmol/L, P < 0.001]. The reduction of D-lactate concentration was consistent with the changes in and improvement of plasma glucose [450.45 (201.80) vs 170.81 (52.43) mg/dL], [beta]-hydroxybutyrate [58.41 (37.38) vs 12.49 (14.89) mg/dL], bicarbonate [13.12 (6.72) vs 21.94 (3.45) mEq/L], and anion gap [20.09 (5.80) vs 8.27 (2.69) mmol/L] following treatment (all P < 0.001). Plasma L-lactate concentrations were also increased in DKA, but to a lesser degree compared to D-lactate concentrations [2.60 (1.55) vs 1.21 (0.69) mmol/L, P = 0.01]. Linear regression analyses identified a significant correlation of plasma D-lactate concentration with acidosis (bicarbonate, r = -0.575, P < 0.001) and high anion gap (r = 0.593, P < 0.001) (Fig. 1). The contribution of D-lactate to acidosis and anion gap was comparable to that of [beta]-hydroxybutyrate. The contribution of D-lactate and [beta]-hydroxybutyrate to the high anion gap found in DKA was statistically significant(r = 0.593,P < 0.001, and r = 0.642, P < 0.001, respectively).

Under physiologic conditions, D-lactate is present in the human body at low concentrations (4). Blood concentrations of D-lactate are increased in diabetes, and particularly in DKA in humans (3). D-lactate is generated by degradation of methylglyoxal, an intermediate glucose metabolite, through the glyoxalase system (3, 5). High concentrations of D-lactate can induce severe metabolic acidosis, resulting in neurological symptoms and encephalopathy. In hyperglycemic disorders such as diabetes mellitus and DKA, methylglyoxal production is greatly increased (3, 5). Consistent with our previous finding, the increased D-lactate concentration is inversely associated with bicarbonate concentration and positively correlated with the increasing anion gap. Reduction of plasma D-lactate concentrations correlated well with improvement of bicarbonate concentrations and anion gap following treatment.

In conclusion, our findings suggest a large contribution of plasma D-lactate to the metabolic acidosis and high anion gap in DKA. Inclusion of the measurement of plasma D-lactate concentrations helps to account for the anion gap and the severity of metabolic acidosis in patients with DKA. Measurement of plasma D-lactate is important in predicting the severity of DKA as characterized by acidosis and high anion gap and monitoring DKA progression.

Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.

Authors' Disclosures or Potential Conflicts of Interest: Upon manuscript submission, all authors completed the author disclosure form. Disclosures and/or potential conflicts of interest:

Employment or Leadership: None declared. Consultant or Advisory Role: None declared. Stock Ownership: None declared. Honoraria: None declared.

Research Funding: L. Lu, the National Natural Science Foundation of China, grant 81170257/H0215; Q. Meng, American Association for Clinical Chemistry's Van Slyke Foundation, research grant.

Expert Testimony: None declared.

Patents: None declared.

References

(1.) Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2006;29:2739-48.

(2.) Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011;57:e1-47.

(3.) Lu J, Zello GA, Randell E, Adeli K, Krahn J, Meng QH. Closing the anion gap: contribution of D-lactate to diabetic ketoacidosis. Clin Chim Acta 2011;412:286-91.

(4.) Ewaschuk JB, Naylor JM, Zello GA. D-lactate in human and ruminant metabolism. J Nutr 2005; 135:1619-25.

(5.) Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 2007;40: 1232-9.

JinshuangBo [1]

Wei Li [1]

Zengqiang Chen [2]

Daniel G. Wadden [3]

Edward Randell [3]

Huaibin Zhou [1]

Jianxin Lu [1]

Qing H. Meng [4] *

[1] Key Laboratory of Laboratory Medicine Ministry of Education Zhejiang Provincial Key Laboratory of Medical Genetics School of Laboratory Medicine Wenzhou Medical College Wenzhou, China

[2] Department of Laboratory Medicine First Affiliated Hospital of Wenzhou Medical College Wenzhou, China

[3] Laboratory Medicine Faculty of Medicine Memorial University St. John's, NL, Canada

[4] Department of Laboratory Medicine The University of Texas Anderson Cancer Center Houston, TX

* Address correspondence to this author at: Department of LaboratoryMedicine University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. R4.1441G, Unit 37 Houston, TX 77030 Fax713-792-4793 E-mail qhmeng@mdanderson.org
COPYRIGHT 2013 American Association for Clinical Chemistry, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Letters to the Editor
Author:Bo, Jinshuang; Li, Wei; Chen, Zengqiang; Wadden, Daniel G.; Randell, Edward; Zhou, Huaibin; Lu, Jian
Publication:Clinical Chemistry
Article Type:Letter to the editor
Date:Sep 1, 2013
Words:1153
Previous Article:Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community...
Next Article:Ninety-minute vs 3-h performance of high-sensitivity cardiac troponin assays for predicting hospitalization for acute coronary syndrome.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters